Meet the Downtown Chicago Melanoma Team
The melanoma team in Dermatology at Northwestern Medicine consists of experts in the diagnosis and management of early melanoma. Our team includes:
Meet the Downtown Chicago Dermatologic Surgery Team
Our team works closely with our dermatologic surgery team. They provide Mohs surgery for people with lentigo maligna and melanoma in situ. The dermatologic surgery team includes:
Meet the Downtown Chicago Surgical Oncology Team
For patients with advanced melanomas, our dermatology team works closely with colleagues in surgical oncology focused in melanoma and medical oncology focused on melanoma care. This team includes:
Director of the Melanoma Clinic, IDP Foundation Professor of Skin Cancer Research, Professor of Dermatology, Pathology and Pediatrics
Pedram Gerami, MD
Primary Specialty: Dermatology
Dr. Gerami is the IDP professor of Skin Cancer Research. Selected to the Best Doctors in America 2019–2020, Dr. Gerami is the Director of the Skin Cancer Institute of Northwestern Medical Group (SCIN-Med). He is also the Director of the Melanoma Program in the Skin Cancer Institute and the Melanoma Clinic in the Department of Dermatology. His clinical and research interests mainly focus on melanoma skin cancer, atypical nevi and borderline melanocytic tumors. These include Spitz tumors, that may be difficult to classify. As a dermatologist, dermatopathologist and researcher focused in caring for patients with melanoma and atypical nevi, he has a unique perspective on the behavior of melanocytic neoplasms. His interests include how to use clinical, histologic and molecular methods to optimize diagnostic accuracy and best predict the behavior of melanocytic neoplasms. He is also interested in creating diagnostic methods for melanoma at its earliest and most curable stage. In clinic, he mainly cares for patients with melanoma or atypical nevi. He is recognized internationally for his expertise in the clinical and histologic diagnosis of melanoma. His expertise in the pathologic diagnosis of melanoma draws over 1,500 second opinion cases both from within and outside of the United States per year. As a researcher, he is focused on developing newer molecular-based methods to help distinguish melanoma from nevi and predict the behavior of melanoma. He is also interested in developing methods for diagnosis of melanoma at the earliest possible stage.
Assistant Professor of Dermatology
Xiaolong Zhou, MD
Primary Specialty: Dermatology
Dr. Zhou focuses on cutaneous oncology and complex skin diseases. He attends on the inpatient dermatology consult service and multidisciplinary cutaneous T cell lymphoma (CTCL) clinic. He is also a pigmented lesion specialist and co-manages the extracorporeal photopheresis unit. As a physician-scientist, he studies the role of the microbiome in skin cancer, with a current focus on skin lymphomas. He has been a recipient of the Dermatology Foundation Medical Dermatology Career Development Award and Cutaneous Lymphoma Foundation Catalyst Grant. His research is supported by the Dermatology Foundation, Cutaneous Lymphoma Foundation, NUCATS/NIH KL2 program and by an American Cancer Society institutional research grant. Dr. Zhou received his BA from Harvard University and his MD from Duke University School of Medicine. He completed his Internal Medicine internship at Santa Clara Valley Medical Center, dermatology residency at Jackson Memorial Hospital / University of Miami and T32 postdoctoral fellowship in cutaneous oncology at Northwestern University. He is experienced in surgical and non-surgical treatments for skin cancers and the use of conventional and novel therapeutics for complex skin diseases. He also serves as principal investigator for several clinical trials in dermatology.
Chrome
Edge
Safari
Firefox